Predictors of mortality among TB-HIV Co-infected patients being treated for tuberculosis in Northwest Ethiopia: A retrospective cohort study

BMC Infectious Diseases

Volumn 13, Issue 1, 2013, Pages

  Sileshi, Balewgizie ^a   Deyessa, Negussie ^b   Girma, Belaineh ^c   Melese, Muluken ^c   Suarez, Pedro ^d  

^a HARAMAYA UNIVERSITY   (Ethiopia)

^b ADDIS ABABA UNIVERSITY   (Ethiopia)

^c USAID   (Ethiopia)

^d MANAGEMENT SCIENCES FOR HEALTH   (United States)

Author keywords

Co infection; Mortality; Predictors; TB HIV

Indexed keywords

ANTIRETROVIRUS AGENT; COTRIMOXAZOLE;

ADULT; AGE DISTRIBUTION; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE COURSE; ETHIOPIA; FEMALE; FUNCTIONAL STATUS; HEALTH CARE FACILITY; HEALTH SERVICE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; MORTALITY; PROBABILITY; RETROSPECTIVE STUDY; SEX DIFFERENCE;

ADULT; ANTI-RETROVIRAL AGENTS; ANTITUBERCULAR AGENTS; COHORT STUDIES; COINFECTION; ETHIOPIA; FEMALE; HIV INFECTIONS; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; PREVALENCE; RETROSPECTIVE STUDIES; TUBERCULOSIS;

EID: 84879490190     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-13-297     Document Type: Article

References (25)

1. Federal Minister of Health Implementation Guideline for TB/HIV Collaborative Activities in Ethiopia 2007, Addis Ababa: Federal Ministry of Health, Federal Minister of Health.
2. World Health Organization Interim policy on collaborative TB/HIV activities 2004, Geneva: World Health Organization, World Health Organization.
3. Kwan CK, Ernst JD. HIV and Tuberculosis: a deadly human syndemic. Clin Microbiol Rev 2011, 24(2):351-376. Apr, 10.1128/CMR.00042-10, 3122491, 21482729.
4. Dean GL, Edwards SG, Ives NJ, Matthews G, Fox EF, Navarante L, Fisher M, Taylor GP, Miller R, Taylor CB, de Ruiter A, Pozniak AL. Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy. AIDS 2002, 16:75-83. 10.1097/00002030-200201040-00010, 11741165.
5. World Health Organization Treatment of tuberculosis guidelines 2010, Geneva: World Health Organization, 4, World Health Organization.
6. Burman WJ. Issues in the management of HIV related tuberculosis. Clin Chest Med 2005, 2:283-294.
7. World Health Organization Treatment of Tuberculosis: Guidelines for National Programmes 2003, Geneva: World Health Organization, 3, World Health Organization.
8. Cain KP, Anekthananon T, Burapat C, Akksilp S, Mankhatitham W, Srinak C, Nateniyom S, Sattayawuthipong W, Tasaneeyapan T, Varma JK. Causes of death in HIV-infected persons who have tuberculosis, Thailand. Emerg Infect Dis 2009, 15(2):258-264. February, 10.3201/eid1502.080942, 2657626, 19193270.
9. Gadkowski LB, Hamilton CD, Allen M, Fortenberry ER, Luffman J, Zeringue E, Stout JE. HIV-specific health care utilization and mortality among Tuberculosis/HIV coinfected persons. AIDS Patient Care STDS 2009, 23(10):845-851. October, 10.1089/apc.2009.0030, 2832656, 19803793.
10. Raizada N, Chauhan LS, Babu BS, Thakur R, Khera A, Wares DF, Sahu S, Bachani D, Rewari BB, Dewan PK. Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in India. PLoS One 2009, 4(6):e5999. 10.1371/journal.pone.0005999, 2695556, 19543396.
11. Manosuthi W, Chottanapand S, Thongyen S, Chaovavanich A, Sungkanuparph S. Survival rate and risk factors of mortality among TB/HIV co-infected patients with and without antiretroviral therapy. Acquir Immune Defic Syndr 2006, 43(1):42-46. September.
12. Varma JK, Nateniyom S, Akksilp S, Mankatittham W, Sirinak C, Sattayawuthipong W, Burapat C, Kittikraisak W, Monkongdee P, Cain KP, Wells CD, Tappero JW. HIV care and treatment factors associated with improved survival during TB treatment in Thailand: an observational study. BMC Infect Dis 2009, 42(9). April.
13. Sanguanwongse N, Cain KP, Suriya P, Nateniyom S, Yamada N, Wattanaamornkiat W, Sumnapan S, Sattayawuthipong W, Kaewsa-ard S, IngKaseth S, Varma JK. Antiretroviral therapy for HIV-infected tuberculosis patients saves lives but needs to be used more frequently in Thailand. J Acquir Immune Defic Syndr 2008, 48:181-189. 10.1097/QAI.0b013e318177594e, 18520676.
14. Umphonsathien M, Sungkanuparph S. Early initiation of antiretroviral therapy in HIV/Tuberculosis co-infection and immune reconstitution inflammatory syndrome. J Infect Dis Antimicrob Agents 2011, 28:15-23.
15. Worodria W, Massinga-Loembe M, Mazakpwe D, Luzinda K, Menten J, Van Leth F, Kizza HM, Kestens L, Mugerwa RD, Reiss P, Colebunders R. Incidence and predictors of mortality and the effect of tuberculosis immune reconstitution inflammatory syndrome in a cohort of TB/HIV patients commencing antiretroviral therapy. J Acquir Immune Defic Syndr 2011, 58(1):32-37. 10.1097/QAI.0b013e3182255dc2, 21654499.
16. MacPherson P, Dimairo M, Bandason T, Zezai A, Munyati SS, Butterworth AE, Mungofa S, Rusakaniko S, Fielding K, Mason PR, Corbett EL. Risk factors for mortality in smear-negative tuberculosis suspects: a cohort study in Harare, Zimbabwe. Int J Tuberc Lung Dis 2011, 15(10):1390-1396. 10.5588/ijtld.11.0056, 3272461, 22283900.
17. Vijay S, Kumar P, Chauhan LS, Narayan Rao SV, Vaidyanathan P. Treatment outcome and mortality at one and half year follow-Up of HIV infected TB patients under TB control programme in a District of South India. PLoS One 2011, 6(7):e21008. 10.1371/journal.pone.0021008, 3144198, 21814542.
18. Akksilp S, Karnkawinpong O, Wattanaamornkiat W, Viriyakitja D, Monkongdee P, Sitti W, Rienthong D, Siraprapasiri T, Wells CD, Tappero JW, Varma JK. Antiretroviral therapy during tuberculosis treatment and marked reduction in death rate of HIV infected patients, Thailand. Emerg Infect Dis 2007, 13(7):1001-1007. 10.3201/eid1307.061506, 2878231, 18214171.
19. Straetemans M, Glaziou P, Bierrenbach AL, Si Smanidis C, Van der Werf MJ. Assessing tuberculosis case fatality ratio: a meta-analysis. PLoS ONE 2011, 6(6):e20755J.
20. Zachariah R, Fitzgerald M, Massaquoi M, Acabu A, Chilomo D, Salaniponi FML, Harries AD. Does antiretroviral treatment reduce case fatality among HIV-positive patients with tuberculosis in Malawi?. Int J Tuberc Lung Dis 2007, 11(8):848-853.
21. Moolphate S, Aung MN, Nampaisan O, Nedsuwan S, Kantipong P, Suriyon N, Hansudewechakul C, Yanai H, Yamada N, Ishikawa N. Time of highest tuberculosis death risk and associated factors: an observation of 12 years in northern Thailand. Int J Gen Med 2011, 4:181-190. February, 3068883, 21475634.
22. Harries AD, Zachariah R, Lawn SD. Providing HIV care for co-infected tuberculosis patients: a perspective from sub-Saharan Africa. Int J Tuberc Lung Dis 2009, 13:6-16.
23. Nahid P, Gonzalez LC, Rudoy I, de Jong BC, Unger A, Kawamura LM, Osmond DH, Hopewell PC, Daley CL. Treatment outcomes of patients with HIV and tuberculosis. Am J Respir Crit Care Med 2003, 167:603.
24. Franke MF, Robins JM, Mugabo J, Kaigamba F, Cain LE, Fleming JG, Murray MB. Effectiveness of early antiretroviral therapy initiation to improve survival among HIV infected adults with tuberculosis: a retrospective cohort study. PLoS Med 2011, 8(5):e1001029. 10.1371/journal.pmed.1001029, 3086874, 21559327.
25. Lulu K, Berhane Y. The use of simplified verbal autopsy in identifying causes of adult death in a predominantly rural population in Ethiopia. BMC Publ Health 2005, 5(58).